Abnormal T-Cell Activation And Cytotoxic T-Cell Frequency Discriminates Symptom Severity In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 6, 2025
Myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
is
a
debilitating
but
poorly-understood
disease.
ME/CFS
symptoms
can
range
from
mild
to
severe,
and
include
immune
system
effects
alongside
incapacitating
post-exertional
disease
exacerbation.
In
this
study,
we
examined
immunological
profiles
of
people
living
with
by
flow
cytometry,
focusing
on
cytotoxic
cells,
determine
whether
mild/moderate
(n=
43)
or
severe
(n=53)
expressed
different
markers.
We
found
that
had
increased
expression
effector
molecules
enhanced
proportions
early-immunosenescence
determined
the
CD28
-
CD57
phenotype,
indicative
persistent
viral
infection.
contrast,
higher
activated
circulating
lymphocytes,
CD69
+
CD38
expression,
more
pro-inflammatory
cytokines,
including
IFNγ,
TNF
IL-17,
following
stimulation
in
vitro
,
prolonged
non-specific
inflammation.
These
changes
were
consistent
across
cell
types
CD8
T
mucosal
associated
invariant
cells
Natural
Killer
indicating
generalised
altered
responses
innate
adaptive
system.
differences
likely
reflect
pathogenesis
mechanisms
occurring
two
clinical
groups,
opening
up
opportunities
for
development
prognostic
markers
stratified
treatments.
Язык: Английский
The Microbiota-Gut-Brain Axis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Narrative Review of an Emerging Field
European Journal of Translational Myology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 12, 2025
The
intricate
relationship
between
gut
microbiota
and
the
brain
has
emerged
as
a
pivotal
area
of
research,
particularly
in
understanding
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS).
This
complex
condition
is
characterized
by
debilitating
fatigue,
cognitive
dysfunction,
wide
array
systemic
manifestations,
posing
significant
challenges
for
diagnosis
treatment.
Recent
studies
highlight
microbiota-gut-brain
axis
crucial
pathway
ME/CFS
pathophysiology,
suggesting
that
alterations
microbial
composition
may
impact
immune
responses,
neurochemical
signaling,
neuronal
health.
narrative
review
systematically
explores
English-language
scholarly
articles
from
January
1995
to
2025,
utilizing
databases
such
PubMed,
Scopus,
Web
Science.
findings
underscore
potential
targeted
therapeutic
interventions
aimed
at
correcting
dysbiosis.
As
research
progresses,
deeper
connection
could
lead
innovative
approaches
managing
ME/CFS,
ultimately
enhancing
quality
life
affected
individuals.
Язык: Английский
Possible Racial Disparities in the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
International Journal of Environmental Research and Public Health,
Год журнала:
2025,
Номер
22(2), С. 280 - 280
Опубликована: Фев. 14, 2025
Myalgic
encephalomyelitis
(ME/CFS)
a
chronic,
disabling
illness
with
no
established
etiopathology.
It
has
been
indicated
in
some
population-based
studies
that
Black
and
ethnic
minority
populations
are
underdiagnosed
ME/CFS.
The
aims
of
the
present
study
were
to
(1)
identify
agreement
between
receiving
an
ME/CFS
diagnosis
meeting
diagnostic
criteria,
(2)
demographic
characteristics
associated
diagnosis,
(3)
explore
patient
satisfaction
healthcare.
Self-reported
medical
history
symptoms
collected
via
online
survey
from
respondents
without
fatigue.
self-reporting
Center
for
Disease
Control's
(CDC)
criteria
or
Institute
Medicine
(IOM)
was
assessed
Cohen's
kappa.
Patient
predicting
physician
analyzed
logistic
regression.
Associations
demographics,
healthcare
chi-square
tests
independence.
There
1110
responses.
reporting
fair
(CDC:
κ
=
0.29;
SE
0.02;
IOM:
0.28,
0.03).
White
had
2.94
greater
odds
being
diagnosed
than
non-White
respondents.
Having
dissatisfaction
(χ2
(3,
N
1063)
14.17,
p
0.003).
findings
suggest
racial
disparities
processes
Язык: Английский
From human herpes virus‐6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID
Journal of Medical Virology,
Год журнала:
2024,
Номер
96(8)
Опубликована: Авг. 1, 2024
Inflammation
and
autoimmune
responses
contribute
to
the
pathophysiology
of
Long
COVID,
its
affective
chronic
fatigue
syndrome
symptoms,
labeled
"the
physio-affective
phenome."
To
investigate
whether
COVID
phenome
are
linked
autoimmunity
tight
junction
proteins,
zonulin
occludin
(ZOOC),
immune
reactivity
lipopolysaccharides
(LPS),
latter
associated
with
signs
human
herpes
virus-6
(HHV-6)
reactivation,
directed
against
oligodendrocyte
neuronal
including
myelin
basic
protein.
IgA/IgM/IgG
severe
acute
respiratory
coronavirus
2
(SARS-CoV-2),
HHV-6,
ZOOC,
C-reactive
protein
(CRP),
advanced
oxidation
products
(AOPPs),
were
measured
in
90
patients
healthy
controls.
The
was
conceptualized
as
a
factor
extracted
from
physical
symptom
domains.
Neural
network
identified
IgA
LPS
(IgA-LPS),
IgG-ZOOC,
IgG-LPS,
IgA-ZOOC
important
variables
diagnosis
an
area
under
ROC
curve
0.755.
Partial
Least
Squares
analysis
showed
that
40.9%
variance
explained
by
CRP,
IgA-myelin
(MBP),
IgG-MBP.
A
large
part
variances
both
MBP
(36.3%-39.7%)
(IgA
IgG)
ZOOC.
strongly
indicants
HHV-6
which
turn
increased
IgM-SARS-CoV-2.
Autoimmunity
components
junctions
bacterial
translocation
may
be
involved
COVID's
phenome.
Язык: Английский
BioMapAI: Artificial Intelligence Multi-Omics Modeling of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Июнь 28, 2024
Chronic
diseases
like
ME/CFS
and
long
COVID
exhibit
high
heterogeneity
with
multifactorial
etiology
progression,
complicating
diagnosis
treatment.
To
address
this,
we
developed
BioMapAI,
an
explainable
Deep
Learning
framework
using
the
richest
longitudinal
multi-'omics
dataset
for
to
date.
This
includes
gut
metagenomics,
plasma
metabolome,
immune
profiling,
blood
labs,
clinical
symptoms.
By
connecting
asymptom
matrix,
BioMapAI
identified
both
disease-
symptom-specific
biomarkers,
reconstructed
symptoms,
achieved
state-of-the-art
precision
in
disease
classification.
We
also
created
first
connectivity
map
of
these
'omics
healthy
states
revealed
how
microbiome-immune-metabolome
crosstalk
shifted
from
ME/CFS.
Thus,
proposed
several
innovative
mechanistic
hypotheses
ME/CFS:
Disrupted
microbial
functions
-
SCFA
(butyrate),
BCAA
(amino
acid),
tryptophan,
benzoate
lost
connection
lipids
bile
acids,
activated
inflammatory
mucosal
cells
(MAIT,
γδT
cells)
INFγ
GzA
secretion.
These
abnormal
dynamics
are
linked
key
including
gastrointestinal
issues,
fatigue,
sleep
problems.
Язык: Английский
Chronic Fatigue Syndrome: Diagnosis, Treatment, and Future Direction
B. Sue Graves,
Mitsu Patel,
Hailey Newgent
и другие.
Cureus,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 1, 2024
Myalgic
encephalomyelitis
(ME),
also
known
as
chronic
fatigue
syndrome
(CFS),
is
a
complex,
condition
marked
by
persistent,
debilitating
that
not
alleviated
rest
and
often
worsens
with
physical
or
mental
exertion.
Along
fatigue,
patients
experience
various
symptoms,
including
cognitive
impairments,
post-exertional
malaise,
muscle
joint
pain,
sleep
disturbances,
immune
system
dysfunction.
Diagnosing
CFS/ME
challenging
due
to
the
absence
of
definitive
biomarkers,
overlap
symptoms
other
conditions,
lack
standardized
diagnostic
criteria.
This
comprehensive
literature
review
aims
contribute
understanding
CFS/ME,
its
diagnosis,
pathophysiology,
differential
treatment,
future
directions.
Язык: Английский
From HHV-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Июнь 30, 2024
Abstract
Background
Inflammation
and
autoimmune
responses
contribute
to
the
pathophysiology
of
Long
COVID,
its
affective
chronic
fatigue
syndrome
(CFS)
symptoms,
labeled
“the
physio-affective
phenome.”
Objectives
To
investigate
whether
COVID
phenome
are
linked
autoimmunity
tight
junction
proteins,
zonulin
occludin
(ZOOC),
immune
reactivity
lipopolysaccharides
(LPS),
latter
associated
with
signs
human
herpes
virus-6
reactivation
(HHV-6),
directed
against
oligodendrocyte
neuronal
including
myelin
basic
protein
(MBP).
Methods
IgA
/
IgM/IgG
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2),
HHV-6,
ZOOC,
C-reactive
(CRP)
advanced
oxidation
products
(AOPP),
were
measured
in
90
patients
healthy
controls.
The
was
conceptualized
as
a
factor
extracted
from
physical
symptom
domains.
Results
Neural
network
identified
LPS
(IgA-LPS),
IgG-ZOOC,
IgG-LPS,
IgA-ZOOC
most
important
variables
diagnosis
an
area
under
ROC
curve
0.755.
Partial
Least
Squares
analysis
showed
that
40.9%
variance
explained
by
CRP,
IgA-MPB
IgG-MBP.
A
large
part
variances
both
MBP
(36.3-39.7%)
(IgA
IgG)
ZOOC.
strongly
indicants
HHV-6
reactivation,
which
turn
increased
IgM-SARS-CoV-2.
Conclusions
Autoimmunity
components
junctions
bacterial
translocation
may
be
involved
COVID’s
phenome.
Язык: Английский